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Biocatalysis
Enantiocomplementary Epoxidation Reactions Catalyzed by an
Engineered Cofactor-Independent Non-natural Peroxygenase
Guangcai Xu, Michele Crotti, Thangavelu Saravanan, Kim M. Kataja, and Gerrit J. Poelarends*
Abstract: Peroxygenases are heme-dependent enzymes that
use peroxide-borne oxygen to catalyze a wide range of
oxyfunctionalization reactions. Herein, we report the engineer-
ing of an unusual cofactor-independent peroxygenase based on
a promiscuous tautomerase that accepts different hydroper-
oxides (t-BuOOH and H2O2) to accomplish enantiocomple-
mentary epoxidations of various a,b-unsaturated aldehydes
(citral and substituted cinnamaldehydes), providing access to
both enantiomers of the corresponding a,b-epoxy-aldehydes.
High conversions (up to 98 %), high enantioselectivity (up to
98% ee), and good product yields (50–80%) were achieved.
The reactions likely proceed via a reactive enzyme-bound
iminium ion intermediate, allowing tweaking of the enzymes
activity and selectivity by protein engineering. Our results
underscore the potential of catalytic promiscuity for the
engineering of new cofactor-independent oxidative enzymes.
Peroxygenases are oxidative enzymes catalyzing the inser-
tion of an oxygen atom into a variety of substrates using
peroxide-borne oxygen instead of dioxygen.[1] Earlier studies
have mainly focused on the peroxygenase activity of chloro-
peroxidases that normally catalyze peroxide-driven halogen-
ation of organic compounds[2] and engineered cytochrome
P450 monooxygenases that are able to promote peroxide-
mediated hydroxylation reactions.[3] However, since the
discovery of the unspecific peroxygenase AaeUPO in
2004,[4] which uses hydrogen peroxide to catalyze diverse
oxyfunctionalization reactions including oxidations, sulfoxi-
dations, epoxidations and hydroxylations,[5] there has been an
increasing interest to discover and develop novel peroxyge-
nases. Note that peroxygenases are cofactor-dependent
enzymes, typically relying on heme to react with hydrogen
peroxide, forming an oxoferryl-heme as the actual oxygen-
ating species to promote oxyfunctionalization reactions.[1, 5a,6]
In this study, we report the engineering of an unusual
cofactor-independent peroxygenase based on the promiscu-
ous peroxygenase activity of the enzyme 4-oxalocrotonate
tautomerase (4-OT). This engineered non-natural peroxyge-
nase accepts different hydroperoxides (t-BuOOH and H2O2)
to achieve enantiocomplementary epoxidations of various
a,b-unsaturated aldehydes, providing access to both enantio-
mers of the resultant a,b-epoxy-aldehydes with high enantio-
meric excess (up to 98 %). Our results showcase the potential
of catalytic promiscuity for the creation of new cofactor-
independent oxidative enzymes.
We have recently demonstrated that 4-OT can catalyze
the Michael addition of nitromethane to cinnamaldehyde via
an enzyme-bound iminium ion intermediate, which is formed
between cinnamaldehyde and the catalytic active site Pro-
1 residue.[7] In this study, we examined if this catalytic
mechanism of 4-OT could be exploited for other useful
synthetic applications, and envisioned that substituting nitro-
methane with t-BuOOH could trigger a CO bond formation
between the reactive enzyme-bound iminium ion species and
t-BuOOH (Supporting Information, Scheme S1). The result-
ing enamine intermediate may undergo ring closure to
construct the final epoxide moiety. To our delight, when
wild-type 4-OT (0.33 mgmL1) was incubated at room
temperature with 200 mm t-BuOOH (1, Figure 1) and 1 mm
cinnamaldehyde (2a) in 20 mm sodium phosphate buffer
(pH 7.3) containing 5% (v/v) EtOH, 38% of substrate 2a was
consumed within 48 h and the corresponding a,b-epoxy-
aldehyde 3a was identified by GC-MS analysis. Chiral HPLC
analysis of the alcohol derivative of 3a revealed the product
to be (2R,3S)-3 a with an e.r. of 62:38 and a d.r. of 92:8 (syn/
anti). The S configuration of the C3 carbon of 3a indicates that
t-BuOOH selectively attacks cinnamaldehyde from the re-
face, similar to what was previously observed for the nitro-
methane addition reaction.[7] These results demonstrated that
4-OT has low-level promiscuous peroxygenase activity and
may possibly serve as a template to construct a cofactor-
independent peroxygenase.
Motivated by these initial findings, a mutability-land-
scape-guided protein engineering approach[8] was applied to
enhance the promiscuous peroxygenase activity of wild-type
4-OT. For this, a previously constructed collection of 4-OT
genes encoding nearly all possible single-mutant variants of 4-
OT[9] was screened to identify hotspot positions in the protein
where mutations give improved peroxygenase activity.
Improved variants were identified by monitoring the deple-
tion of substrate 2 a in a spectrophotometric kinetic assay in
multiwell plates (see Supporting Information). Interestingly,
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six mutations at position F50 significantly improved (> 5-fold)
the peroxygenase activity, with F50A (10-fold enhanced
activity) and F50V (25-fold enhanced activity) being the
best mutant enzymes (Figure 1). Several mutations at posi-
tions Q4, I41, M45, and H49 also resulted in enzyme variants
with 2- to 5-fold enhanced activity compared to wild-type 4-
OT, including mutants Q4Y, I41Y, M45I, and H49T. The most
beneficial mutations, F50V and F50A, were subsequently
combined with mutations at other hotspot positions by using
site-saturation mutagenesis (Table S2). Activity screening of
the seven mutant libraries resulted in the identification of
three double mutants (Q4Y/F50V, Q4F/F50A and M45I/
F50A) with around 1.6- to 3.5-fold enhanced activity com-
pared to the parental enzymes. Based on these results, the
mutant libraries Q4X/M45I/F50A, Q4Y/M45X/F50A, Q4F/
M45X/F50A, and Q4Y/M45I/F50X were constructed
(Table S2). Screening of these four libraries led to the
discovery of the triple mutant Q4Y/M45I/F50A (YIA) that
showed a remarkable 60-fold enhancement in activity for the
epoxidation of 2a compared to the wild-type enzyme
(Figure 1). Notably, this mutant enzyme also has enhanced
enantioselectivity, allowing the production of (2R,3S)-3 a with
high enantiopurity (e.r. = 98:2). Replacement of Pro-1 with an
alanine in 4-OT(YIA) led to a 210-fold decrease in t-
BuOOH-dependent epoxidation of 2 a (Figure S31), provid-
ing support for a reaction mechanism that proceeds via
iminium ion formation between the active site Pro-1 residue
and the a,b-unsaturated aldehyde substrate (Scheme S1).
With the improved 4-OT mutant YIA in hand, the
substrate scope of this enzyme was explored by testing a set
of a,b-unsaturated aldehydes using t-BuOOH as oxidant. The
results showed that 4-OT(YIA) has a broad substrate scope,
accepting ortho-, meta-, and para-substituted cinnamalde-
hydes (2 a–i, Figure 2), and catalyzes their epoxidation with
good conversions (94–97%) to yield the corresponding
products (3a–i) with excellent enantiopurity (e.r. up to
99:1). The d.r. values (up to 92:8) obtained indicate that the
enzyme has good stereocontrol over both carbons of the
double bond of 2. The enzyme also accepts the aliphatic a,b-
unsaturated aldehyde citral (2j) with good enantioselectivity,
moderate diastereoselectivity, and excellent regioselectivity
(Figure 2). All epoxide products have the syn configuration
with 2R,3S being the major enantiomer, indicating that t-
BuOOH exclusively attacked from the re-face of the enzyme-
bound iminium ion intermediate (Figure 3). Note that while
the enzymatic a,b-epoxy-aldehyde products 3 have a 2R,3S
configuration, the corresponding a,b-epoxy-alcohols have
a 2S,3S configuration. This deviant configuration of the a,b-
epoxy-alcohols is due to different prioritization of the
substituents at the C2 chiral center relative to their a,b-
epoxy-aldehyde precursors.
Given that t-BuOOH is a relatively large hydroperoxide,
we investigated if the use of a small hydroperoxide such as
H2O2 would change the preference of attack to the si-face
(Figure 3). Again, compound 2a was used as a substrate for
initial testing with H2O2 as oxidant and mutant 4-OT(YIA) as
catalyst. Notably, the epoxidations with H2O2 showed rela-
tively high non-enzymatic (background) reaction rates when
applying the same conditions as used with t-BuOOH. To
suppress the background reaction, without diminishing the
enzymatic activity, the pH of the reaction was lowered from
7.3 to 6.3 (Figure S1). Gratifyingly, the results showed that the
use of H2O2 not only inverted the stereochemistry of the
reaction, but product 3a was also obtained with good e.r.
(92:8) and d.r. (84:16) values (Figure 2 and Figure 3). Thus, an
enantiocomplementary epoxidation of 2a was achieved by
replacing t-BuOOH by H2O2 as the oxidant. Next, we
evaluated the same set of a,b-unsaturated aldehydes 2b–2j
for 4-OT(YIA)-catalyzed epoxidation reactions using H2O2
(Figure 2). Importantly, the stereo inversions occurred with
all aromatic substrates (2 a–2 i), and high conversions and
good enantio- and diastereoselectivity were observed. Nota-
bly, the epoxidation reaction with the aliphatic substrate citral
(2j) also showed an inversion of diastereoselectivity when
using H2O2 instead of t-BuOOH, resulting in the anti-product
as the major isomer; the syn-product also showed an inverted
enantiomer ratio (Figure S30).
Having achieved enantiocomplementary epoxidation
reactions, we next investigated semi-preparative scale chemo-
enzymatic synthesis of a,b-epoxy-alcohols 4 a–j using 4-OT-
(YIA) as catalyst. With t-BuOOH as oxidant, the reactions
Figure 1. Peroxygenase activity of 4-OT variants. A) Reaction scheme of
4-OT-catalyzed epoxidation of 2a using t-BuOOH as oxidant. B) Com-
parison of the peroxygenase activity of wild-type 4-OT (WT) and
engineered 4-OT variants. C) Reaction progress curves using different
4-OT variants. The initial rate of the 4-OT(YIA)-catalyzed reaction
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were performed with higher substrate concentrations (50 mm
2a, 20 mm 2b–g and 2 j, 5 mm 2 i), maintaining high con-
versions and stereoselectivity with good isolated product
yields (Table 1). Only a minor decrease in enantio- and
diastereoselectivity was observed, most likely due to the non-
enzymatic background reaction, since somewhat longer
reaction times were needed. The semi-preparative scale
synthesis using H2O2 as oxidant was also attempted using
Figure 2. Substrate scope of the epoxidation reactions catalyzed by 4-OT(YIA) (Q4Y/M45I/F50A) using t-BuOOH or H2O2 as the oxidant. Reaction
conditions: 2 (1 mm), t-BuOOH (100 mm) or H2O2 (25 mm), 4-OT(YIA) (0.1 mgmL
1), NaPi buffer (20 mm), 5% (v/v) EtOH (MeCN for 2 f, 2g
and 2h). Conversions were calculated based on the depletion of the absorbance corresponding to substrate 2. Product identifications were
performed by GC-MS analysis. The enzymatic a,b-epoxy-aldehyde products 3 were reduced to the corresponding a,b-epoxy-alcohols with NaBH4
for chiral HPLC analysis. The e.r. , d.r. and absolute stereochemistry of products were determined by chiral HPLC using authentic standards. The
diastereomer ratio (d.r.) is defined as the syn/anti ratio. 2 j : E/Z= 3:2; n.d.: not determined.
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20 mm 2a and 22 mm H2O2. However, it was observed that the
e.r. of the product (isolated as 4a) substantially decreased to
73:27 (92:8 when using 1 mm 2a, Figure 2). We further
explored this unexpected result by testing different concen-
trations of 2a and H2O2 in analytical-scale reactions
(Table S3). The results revealed that an increasing concen-
tration of 2a has a negative effect on the e.r. of the final
product 4 a, while the concentration of H2O2 has no effect
(Table S3). This effect may be caused by the higher concen-
tration of peroxyhydrate (S4) formed between the enzymatic
aldehyde product (3a) and H2O2 when higher substrate (2 a)
concentrations were used (Scheme S2). This peroxyhydrate
can be considered as a large hydroperoxide that, like t-
BuOOH, attacks the iminium ion on the re-face during the
reaction, thus lowering the e.r. of the product. In reactions
with t-BuOOH, the peroxyhydrate (S5) of the enzymatic
aldehyde product (3a) is not a hydroperoxide, and therefore
cannot be accepted by the enzyme as an oxidant. Conse-
quently, the negative effect of high substrate concentrations
on the enantiopurity of the final product was not observed in
4-OT(YIA)-catalyzed epoxidation reactions with t-BuOOH
(Scheme S2).
In summary, we have exploited the catalytic promiscuity









require any cofactors, such
as heme, for catalysis.
While Candida antarctica




enzymatic products were either racemic[10] or reported with-
out demonstrating any enantioselectivity.[11] Notably, several
amino acid and peptide organocatalysts, as well as bovine
serum albumin (BSA), have been shown to catalyze asym-
metric peroxide-driven epoxidations of a,b-unsaturated alde-
hydes and ketones, but these systems offer a more general
mode of catalysis and, with the exception of BSA, often
require the use of organic solvents.[12] In contrast, peroxyge-
nase 4-OT(YIA) uses a distinct active-site process to accom-
plish highly enantioselective epoxidations of a,b-unsaturated
aldehydes, and by using either t-BuOOH or H2O2 to drive the
reaction, access to both product enantiomers can be achieved.
This may suggest that there are two binding pockets for
hydroperoxides in the active site of 4-OT(YIA); one rela-
tively large and hydrophobic pocket at the re-face of the
enzyme-bound iminium ion that preferably binds t-BuOOH
and one relatively small and probably more hydrophilic
pocket at the si-face of the iminium ion that selectively
recruits H2O2 for asymmetric epoxidations (Figure 3). We
have initiated structural studies of 4-OT(YIA) aimed at
elucidating the mechanistic origin of the enantiocomplemen-
tary epoxidation reactions. Furthermore, given that 4-OT-
(YIA) exhibits a moderate specific activity of 48 mUmg1 for
the t-BuOOH-driven epoxidation of 2a, current work in our
Figure 3. Enantiocomplementary epoxidation of 2a catalyzed by 4-OT(YIA) using t-BuOOH or H2O2 as oxidant.
The predominant enzymatic diastereomer has the syn configuration; the minor anti diastereomeric product
presumably is formed by rotation of the C2-C3 bond after addition of the peroxide, but before ring closure.
Table 1: Preparative-scale 4-OT(YIA)-catalyzed epoxidations of a,b-unsaturated aldehydes using t-BuOOH as oxidant.[a]
Entry 2 R1 R2 t [h] Conv. (Yield[%])[b] e.r.[c] d.r.[d] Abs. config.[e]
1[f ] a H Ph 24 93 (52) 98:2 92:8 2S,3S
2 b H o-Cl-Ph 48 85 (55) 93:7 68:32 2S,3S
3 c H m-Cl-Ph 66 85 (68) 94:6 85:15 2S,3S
4 d H p-Cl-Ph 48 91 (62) 97:3 89:11 2S,3S
5 e H p-F-Ph 24 95 (50) 96:4 83:17 2S,3S
6[f ] f H p-Br-Ph 46 98 (80) 98:2 92:8 2S,3S
7 g H p-NO2-Ph 48 92 (64) 97:3 89:11 2S,3S
8 i H o-Me-Ph 45 90 (61) 97:3 80:20 2S,3S
9[g] j Me (CH3)2CCHCH2CH2 96 79 (50) 96:4 60:40 2S,3S
[a] General reaction conditions: 2 (20 mm), t-BuOOH (100 mm), 4-OT(YIA) (0.93 mg mL1) in 20 mm NaPi (sodium phosphate, pH 7.3) buffer with
10% (v/v) EtOH (MeCN for 2 f and 2g), volume =10 mL (5 mL for 2a, 40 mL for 2 f), enzymatic product 3 reduced with NaBH4 to 4 after completion
of the reaction [b] Conversion determined by GC-MS; yield of the diastereomer mixture. [c] syn diastereomer; determined by chiral HPLC. [d] syn/anti.
[e] syn diastereomer; determined by comparison with authentic standards on chiral HPLC. [f ] conc. 2a = 50 mm, conc. 2 f = 5 mm, see supporting
information for details. [g] 2 j : E/Z = 3:2; 1.3 mg mL1 4-OT(YIA).
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group is focused on further improving the peroxygenase
activity of this promising cofactor-independent enzyme,
making use of a recently developed selective colorimetric
“turn-on” probe for efficient engineering of iminium bioca-
talysis.[13] The non-natural peroxygenase activity of 4-OT,
together with its previously reported promiscuous CC bond-
forming Michaelase[7, 9, 14] and aldolase[15] activities, emphasize
the chemical versatility of the 4-OT protein scaffold.
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